ijms-logo

Journal Browser

Journal Browser

Mechanism of Hepatitis B Virus Infection and Antiviral Development

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Microbiology".

Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 2089

Special Issue Editors


E-Mail Website
Guest Editor
Department of Microbiology and Immunology, Hamamatsu University School of Medicine, Shizuoka 431-3192, Japan
Interests: hepatitis virus; human polyoma virus; molecular mechanism of viral carcinogenesis; antiviral drug development

E-Mail Website
Guest Editor
Laboratory of Molecular Genetics, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan
Interests: development of replication-incompetent adenovirus vectors; genome editing using viral vectors; viral vectors expressing multiplex guide RNAs
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Hepatitis B virus (HBV) is a leading cause of liver diseases including hepatic cirrhosis and hepatocellular carcinoma, and chronic infection with this virus is a well-known threat to global health. HBV is the only virus of the Hepadnaviridae family that infects human hepatocytes. It is an enveloped virus with a partial double-stranded circular DNA genome at 3.2 kbp, which is extremely small compared to other DNA viruses. The unique arrangement of the open reading frame, the replication strategy of reverse transcription of the RNA intermediate to generate the DNA genome, and the production of a large number of non-infectious HBs particles in addition to the infectious particles are also characteristic of this virus.

Current therapies include nucleos(t)ide analogs (NUCs), which act directly on viral replication, and immunomodulators such as interferon therapy. NUC therapy suppresses viral replication and improves liver histology. However, long-term NUC administration rarely results in functional cure (HBs seroclearance) of chronic hepatitis, and virologic relapse almost often occurs after treatment is discontinued. Development of antiviral compounds with new mechanisms of action as well as new treatment strategies such as gene therapy are being actively pursued to achieve the goal of functional cure and to improve the remission rate after treatment cessation.

This Special Issue of IJMS is seeking articles (original research articles and comprehensive reviews) that provide new insights into the molecular aspects of regulatory mechanisms of HBV lifecycle and drug discovery research against HBV.

Prof. Dr. Tetsuro Suzuki
Prof. Dr. Izumu Saito
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hepatitis B virus
  • virus infection
  • virus replication
  • antiviral
  • drug development
  • gene therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 13838 KiB  
Article
Development and Use of a Kinetical and Real-Time Monitoring System to Analyze the Replication of Hepatitis C Virus
by Xiaoyu Li, Masahiko Ito, Haruyo Aoyagi, Asako Murayama, Hideki Aizaki, Masayoshi Fukasawa, Takanobu Kato, Takaji Wakita and Tetsuro Suzuki
Int. J. Mol. Sci. 2022, 23(15), 8711; https://doi.org/10.3390/ijms23158711 - 5 Aug 2022
Cited by 1 | Viewed by 1670
Abstract
In microbiological research, it is important to understand the time course of each step in a pathogen’s lifecycle and changes in the host cell environment induced by infection. This study is the first to develop a real-time monitoring system that kinetically detects luminescence [...] Read more.
In microbiological research, it is important to understand the time course of each step in a pathogen’s lifecycle and changes in the host cell environment induced by infection. This study is the first to develop a real-time monitoring system that kinetically detects luminescence reporter activity over time without sampling cells or culture supernatants for analyzing the virus replication. Subgenomic replicon experiments with hepatitis C virus (HCV) showed that transient translation and genome replication can be detected separately, with the first peak of translation observed at 3–4 h and replication beginning around 20 h after viral RNA introduction into cells. From the bioluminescence data set measured every 30 min (48 measurements per day), the initial rates of translation and replication were calculated, and their capacity levels were expressed as the sums of the measured signals in each process, which correspond to the areas on the kinetics graphs. The comparison of various HuH-7-derived cell lines showed that the bioluminescence profile differs among cell lines, suggesting that both translation and replication capacities potentially influence differences in HCV susceptibility. The effects of RNA mutations within the 5′ UTR of the replicon on viral translation and replication were further analyzed in the system developed, confirming that mutations to the miR-122 binding sites primarily reduce replication activity rather than translation. The newly developed real-time monitoring system should be applied to the studies of various viruses and contribute to the analysis of transitions and progression of each process of their life cycle. Full article
(This article belongs to the Special Issue Mechanism of Hepatitis B Virus Infection and Antiviral Development)
Show Figures

Figure 1

Back to TopTop